Jessica Vondrak

Jessica Vondrak practices at Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Jessica Vondrak's NPI, 1245687185, was assigned on May 20, 2016. Jessica Vondrak holds Pennsylvania license MD473303.

Jessica Vondrak's primary practice is Pennsylvania Hospital, at 800 Spruce Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 829-3000.

Jessica Vondrak's primary practice is Pennsylvania Hospital in Philadelphia, Pennsylvania, part of University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Jessica Vondrak to 2 more medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jessica Vondrak practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Jessica Vondrak's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Jessica Vondrak is licensed in Pennsylvania.

CMS data shows 645 Medicare services from Jessica Vondrak across 8 procedure codes in 2024, for 207 Medicare patients. Medicare paid $55,963 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 207 Medicare patients who saw Jessica Vondrak in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jessica Vondrak's median patient age at 59, with 47% women.

In 2019, Jessica Vondrak wrote 36 Medicare Part D claims. They cover 3 drugs, with $11,584 in total drug cost. In 2018, CMS named 82 claims across 6 drugs.

Jessica Vondrak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Jessica Vondrak from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $17.